Figure 2
![Figure 2. Survival curves for cancer patients with and without SVT. (A-C) Survival curves for patients with a diagnosis of liver cancer (A), pancreatic cancer (B), or myeloproliferative neoplasm (C) and SVT, and for a matched comparison cohort of cancer patients without SVT (matched by cancer type and stage, sex, age [5-year intervals], and year of diagnosis [5-year intervals]).](https://ash.silverchair-cdn.com/ash/content_public/journal/blood/126/8/10.1182_blood-2015-03-631119/3/957f2.jpeg?Expires=1725282449&Signature=t2jpmDFkV29eqLHR-APWCmWhN8jxO0mdtlyVvitUz8l0Mzon9064RZQgFb4vT7rmuSddYuY7Np-0Dy4li4IQVi3B9McKJaGj8hojOv7TSY8sX7KyMcUmwzUnCapCa6Mxlb5PeKtoVj1QlKbAid9PqAvZS-RK2G8AZtLwtHXNzqe4FSuJf9lsKJOqE6LTgJspRrWdtVtIsqZxW6Q~K-Zz5xkE-YnrNPFfZ0ev5~aQtB3SOTgMHw7PZj4XonGOvQPl7Hqbz-ooKziDF70-Pq3fmXBRQTxGpdAzupQsXb1SWDqyXls5OqUPDeu1wYKWPGf~lykHefMiAEZ8~Q9ASP31ew__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA)
Survival curves for cancer patients with and without SVT. (A-C) Survival curves for patients with a diagnosis of liver cancer (A), pancreatic cancer (B), or myeloproliferative neoplasm (C) and SVT, and for a matched comparison cohort of cancer patients without SVT (matched by cancer type and stage, sex, age [5-year intervals], and year of diagnosis [5-year intervals]).
